328 related articles for article (PubMed ID: 7562043)
1. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
2. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
[TBL] [Abstract][Full Text] [Related]
3. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
5. Prone scintimammography in patients with suspicion of carcinoma of the breast.
Khalkhali I; Mena I; Jouanne E; Diggles L; Venegas R; Block J; Alle K; Klein S
J Am Coll Surg; 1994 May; 178(5):491-7. PubMed ID: 8167887
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
[TBL] [Abstract][Full Text] [Related]
8. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
[TBL] [Abstract][Full Text] [Related]
9. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
10. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
11. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
12. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
[TBL] [Abstract][Full Text] [Related]
13. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
15. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
Klaus AJ; Klingensmith WC; Parker SH; Stavros AT; Sutherland JD; Aldrete KD
AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
[TBL] [Abstract][Full Text] [Related]
16. Scintimammography in the diagnosis of breast cancer.
Clifford EJ; Lugo-Zamudio C
Am J Surg; 1996 Nov; 172(5):483-6. PubMed ID: 8942549
[TBL] [Abstract][Full Text] [Related]
17. The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer.
Danielsson R; Reihnér E; Grabowska A; Boné B
Acta Radiol; 2000 Sep; 41(5):441-5. PubMed ID: 11016763
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
Scopinaro F; Ierardi M; Porfiri LM; Tiberio NS; De Vincentis G; Mezi S; Cannas P; Gigliotti T; Marzetti L
Anticancer Res; 1997; 17(3B):1635-8. PubMed ID: 9179209
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer.
Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A
Breast J; 2003; 9(4):288-94. PubMed ID: 12846862
[TBL] [Abstract][Full Text] [Related]
20. 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer.
Rajkovaca Z; Vuleta G; Matavulj A; Kovacević P; Ponorac N
Bosn J Basic Med Sci; 2007 Aug; 7(3):256-60. PubMed ID: 17848153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
